journal article·2025-07Open access

Mammalian Cell Surface Display for High‐Throughput Protein Engineering of Glycosyltransferases

Ryoma Hombu, Sriram Neelamegham

Small· Volume 21· Issue 27

Abstract

Abstract High‐throughput methods are needed to study structure‐function relationships of mammalian glycosyltransferases due to their essential role in assembling the glycocalyx. Mutations in these enzymes result in Congenital Disorders of Glycosylation, and improvements of enzyme properties can yield new biocatalysts. In this manuscript, a cell‐based glycosyltransferase activity assay is developed using mammalian surface display. It is demonstrated that coupling this approach with click chemistry enables rapid quantification of glycosyltransferase activity. Screening of 1680 different pig ST3Gal1 mutants yielded α(2,3)sialyltransferases with improved enzymatic properties. Using endogenous cell‐surface substrates, the method is extended to other human sialyltransferases, including ST6Gal1, ST3Gal4, and ST6GalNAc2. Additionally, the approach is used to screen putative sialyltransferases from diverse organisms not characterized in the CAZy (Carbohydrate‐Active EnZymes) database. Overall, a facile, robust, high‐throughput, low‐cost method is presented to study glycosyltransferase structure‐function relationships.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Glycosylation and Glycoproteins Research · Monoclonal and Polyclonal Antibodies Research · Carbohydrate Chemistry and Synthesis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biological Engineering & Cell, Gene and Tissue Engineering Center University at Buffalo State University of New York 910 Furnas Hall Buffalo New York 14260‐4200 USA

Department of Chemical and Biological Engineering Biomedical Engineering and Medicine & Cell, Gene and Tissue Engineering Center University at Buffalo State University of New York 906 Furnas Hall Buffalo New York 14260‐4200 USA

Funding

National Heart, Lung, and Blood Institute · National Institute of General Medical Sciences

References (53)

Show source-provided references
1. Stanley P. · Nat Rev Genet. · 2024 · 25 · 715
2. 10.1093/glycob/cww08610.1093/glycob/cww086 ↗
3. 10.1038/s41580-020-00294-x10.1038/s41580-020-00294-x ↗
4. 10.1016/j.sbi.2016.09.01310.1016/j.sbi.2016.09.013 ↗
5. 10.1038/s41589-019-0350-210.1038/s41589-019-0350-2 ↗
6. 10.1093/glycob/cwr03610.1093/glycob/cwr036 ↗
7. 10.1093/bioinformatics/btac70410.1093/bioinformatics/btac704 ↗
8. 10.1016/j.molcel.2019.05.01710.1016/j.molcel.2019.05.017 ↗
9. 10.1016/j.cbpa.2004.02.00310.1016/j.cbpa.2004.02.003 ↗
10. 10.1016/j.cbpa.2024.10245710.1016/j.cbpa.2024.102457 ↗
11. 10.1016/j.biotechadv.2023.10814410.1016/j.biotechadv.2023.108144 ↗
12. 10.3390/ijms2315872510.3390/ijms23158725 ↗
13. 10.1016/j.ejmg.2017.10.01210.1016/j.ejmg.2017.10.012 ↗
14. 10.1186/1475-2859-8-5010.1186/1475-2859-8-50 ↗
15. 10.1038/s41467-022-34029-710.1038/s41467-022-34029-7 ↗
16. 10.1371/journal.pone.015541010.1371/journal.pone.0155410 ↗
17. 10.3389/fmicb.2022.93065810.3389/fmicb.2022.930658 ↗
18. 10.1016/j.biotechadv.2023.10820810.1016/j.biotechadv.2023.108208 ↗
19. 10.1016/j.bbrc.2015.11.13010.1016/j.bbrc.2015.11.130 ↗
20. 10.1021/acs.bioconjchem.8b0052910.1021/acs.bioconjchem.8b00529 ↗
21. 10.1007/978-1-4939-9154-9_1810.1007/978-1-4939-9154-9_18 ↗
22. 10.1038/s41467-019-09608-w10.1038/s41467-019-09608-w ↗
23. 10.1021/jacs.6b0404910.1021/jacs.6b04049 ↗
24. 10.1093/nar/gkt117810.1093/nar/gkt1178 ↗
25. 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.0.CO;2-O10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.0.CO;2-O ↗
26. 10.1038/srep3039210.1038/srep30392 ↗
27. M.‐F.Karwaski W.W Wakarchuk M.Gilbert Protein Expression and Purification Elsevier2002 25 pp.237–240.10.1016/S1046-5928(02)00004-9 ↗
28. 10.1021/bi701472g10.1021/bi701472g ↗
29. 10.1371/journal.pone.016396210.1371/journal.pone.0163962 ↗
30. 10.1074/jbc.M113.46365310.1074/jbc.M113.463653 ↗
31. 10.1093/glycob/cww04610.1093/glycob/cww046 ↗
32. 10.1074/jbc.M113.51904110.1074/jbc.M113.519041 ↗
33. 10.1107/S090744491301541210.1107/S0907444913015412 ↗
34. 10.1093/nar/gkab104510.1093/nar/gkab1045 ↗
35. 10.1021/acscatal.7b0352310.1021/acscatal.7b03523 ↗
36. 10.7717/peerj.578810.7717/peerj.5788 ↗
37. 10.1038/s41592-022-01488-110.1038/s41592-022-01488-1 ↗
38. 10.3389/fbioe.2021.63055110.3389/fbioe.2021.630551 ↗
39. 10.1021/acschembio.1c0068910.1021/acschembio.1c00689 ↗
40. 10.3389/fimmu.2021.79986110.3389/fimmu.2021.799861 ↗
41. 10.1093/protein/gzh01310.1093/protein/gzh013 ↗
42. 10.1021/ja064619y10.1021/ja064619y ↗
43. 10.1016/j.tetlet.2008.02.01810.1016/j.tetlet.2008.02.018 ↗
44. 10.1093/glycob/cwi04110.1093/glycob/cwi041 ↗
45. 10.1021/acschembio.8b0000210.1021/acschembio.8b00002 ↗
46. 10.1038/s41589-020-0622-x10.1038/s41589-020-0622-x ↗
47. 10.1038/s41587-019-0331-810.1038/s41587-019-0331-8 ↗
48. 10.1038/nmeth.403810.1038/nmeth.4038 ↗
49. 10.1016/j.cbpa.2020.09.00110.1016/j.cbpa.2020.09.001 ↗
50. 10.1021/acscentsci.3c0050710.1021/acscentsci.3c00507 ↗
51. 10.1038/s41557-018-0188-310.1038/s41557-018-0188-3 ↗
52. 10.1021/bi901430h10.1021/bi901430h ↗
53. 10.1016/j.cell.2017.11.04110.1016/j.cell.2017.11.041 ↗